CompletedNCT00384332
Two forms of olanzapine for weight gain and digestive hormones in bipolar depression
About this title
Read the official source — NCT00384332Medication studyAges 18–60United StatesBipolarity
Understand this study
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- NashvilleSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJanuary 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 20
- Sponsor
- Vanderbilt University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT00384332
- Official title
Show the full official title
Orally-Disintegrating vs. Regular Olanzapine Tablets: Effects on Weight and GI Hormones
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Nashville
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Vanderbilt University, a university.
Did this study involve medication?
Yes. The study involved medication, including orally-disintegrating olanzapine and regular olanzapine.
Who was this study for?
Listed age limits: 18 years to 60 years.
